WASHINGTON DC (April 3, 2020) — The US Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood.

WASHINGTON DC (April 2, 2020) — On March 1, The US Food and Drug Administration announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.

WASHINGTON DC (March 30, 2020) — The US Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the US. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic.

SPRINGFIELD, ILLINOIS (March 26, 2020) — As the COVID-19 outbreak intensifies in Illinois, and in an effort to respond to the growing need among frontline health-care providers for PPE (Personal Protective Equipment), the Illinois Public Health Association is announcing today that we are donating 30,000 gloves to statewide healthcare providers in the fight against this pandemic.